Lord, Abbett & Co. LLC Neuro Pace Inc Transaction History

Lord, Abbett & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$7.06 - $11.57 $2.51 Million - $4.12 Million	-355,972 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$8.63 - $17.36 $29,764 - $59,874	-3,449 Reduced 0.96%	355,972 $3.59 Million
Q3 2021 Nov 09, 2021	BUY	$15.85 - $25.07 $1.78 Million - $2.81 Million	112,053 Added 45.3%	359,421 $5.7 Million
Q2 2021 Aug 11, 2021	BUY	$19.03 - $26.5 $4.71 Million - $6.56 Million	247,368 New	247,368 $5.89 Million

21.3M

1.3K

100

Ticker NPCE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,846,900
Market Cap $297M
Description
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.